Evidence map›Paper›PMID 36275353›Full record

ReviewHeart international2022

The Hype Surrounding Patent Foramen Ovale Closure and Cryptogenic Stroke: A Walk Through History.

Lekha Racharla, Akhil Kher, Zeel Patel, Theresa Maitz, Bryan Kluck

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heart international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lekha RacharlaDepartment of Cardiology, Lehigh Valley Health Network, Allentown, PA, USA.
Akhil KherDepartment of Cardiology, Lehigh Valley Health Network, Allentown, PA, USA.
Zeel PatelDepartment of Medicine, Lehigh Valley Health Network, Allentown, PA, USA.
Theresa MaitzDepartment of Medicine, Lehigh Valley Health Network, Allentown, PA, USA.
Bryan KluckDepartment of Cardiology, Lehigh Valley Health Network, Allentown, PA, USA.
Lehigh Valley Hospital-Pocono · USLehigh Valley Health Network · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cryptogenic stroke (CS) represents one-third of all ischaemic strokes. Studies have shown approximately that half of patients with CS have concomitant patent foramen ovale (PFO), with clear data supporting paradoxical embolization as an aetiology of CS. This article is the first of a multi-part review and will detail the history of PFO closure and the clinical trials that have evaluated the efficacy of PFO device closure. Data favour PFO closure in CS for reducing stroke in appropriate patients and should be considered as a treatment modality.

Indexed as

Clinical trialscryptogenic strokeGartner Hype Cyclepatent foramen ovalepatent foramen ovale closurepatent foramen ovale device closure

Identifiers

PMID36275353
PMCPMC9524620
OpenAlexW4288779716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.